Skip to Main Content
Legislation Search

S. 925: Credit for Caring Act of 2025

This bill, known as the Credit for Caring Act of 2025, aims to provide tax relief to family caregivers who are working while providing care for qualifying individuals with long-term care needs. Here’s a breakdown of how the bill is structured and what it entails:

Tax Credit for Caregivers

The bill proposes a new tax credit that allows eligible caregivers to receive a credit against their income taxes. Specifically, the credit would grant caregivers:

  • 30% of their qualified expenses for caregiving, provided these expenses exceed $2,000.
  • A maximum credit of $5,000 per taxable year, subject to adjustments for inflation starting in 2026.

Eligibility Criteria

To qualify for this tax credit, the caregiver must meet several criteria:

  • The caregiver must incur qualified expenses for providing care to a "qualified care recipient."
  • The caregiver must have earned income over $7,500 for the taxable year.
  • The care recipient could be the caregiver's spouse or a close family member requiring long-term care (as defined by specific conditions outlined in the bill).

Qualified Care Recipients

The bill defines a "qualified care recipient" as someone who:

  • Is related to the caregiver in specific ways, such as being a spouse or having a familial connection.
  • Has been certified by a licensed healthcare practitioner as needing long-term care for at least 180 consecutive days during the year.

Qualified Expenses

Qualified expenses that caregivers can claim under this credit include:

  • Expenditures for goods, services, and support that assist the qualified care recipient with daily activities and living needs.
  • Costs related to human assistance, such as hiring direct care workers.
  • Expenses for respite care, counseling, and support services related to caregiving.
  • Travel costs directly associated with caregiving duties.
  • Lost wages from unpaid time off due to caregiving responsibilities.

Income Limitations

The credit amount decreases for caregivers whose modified adjusted gross income exceeds certain thresholds:

  • $150,000 for joint returns.
  • $75,000 for single filers or married individuals filing separately.

The decrease is $100 for every $1,000 (or fraction thereof) over these thresholds, ensuring that higher-earning caregivers receive a reduced benefit.

Documentation Requirements

Caregivers must provide proper documentation to claim the credit. This includes the name and taxpayer identification numbers of the care recipient and the healthcare professional who verified the care recipient's status.

Effective Date

The provisions of this bill are set to take effect for taxable years commencing after December 31, 2024.

Relevant Companies

  • AMGN (Amgen Inc.): As a company involved in biopharmaceuticals, Amgen could see increased demand for its products that support long-term care and chronic condition management.
  • HSIC (Henry Schein, Inc.): This company provides health care products, including support technologies for caregivers, which may experience higher sales due to increased caregiver support programs.
  • ABT (Abbott Laboratories): Abbott produces medical devices and diagnostics that could witness increased usage as caregivers seek better health management solutions for the recipients of their care.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

4 bill sponsors

Actions

2 actions

Date Action
Mar. 11, 2025 Introduced in Senate
Mar. 11, 2025 Read twice and referred to the Committee on Finance.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
HSIC logo
HSIC HENRY SCHEIN, INC. - COMMON STOCK
Sale $1,001 - $15,000
Apr 07, 2025 Mar 31, 2025 -3.33%
Congress pfp
Byron Donalds R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 +4.33%
Congress pfp
Byron Donalds R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 +4.33%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Apr 10, 2025 Mar 06, 2025 -0.71%
Congress pfp
Bruce Westerman R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 16, 2025 Mar 03, 2025 -2.37%
Congress pfp
Shelley Moore Capito R / Senate
ABT logo
ABT Abbott Laboratories
Sale (Partial) $1,001 - $15,000
Mar 06, 2025 Feb 24, 2025 +3.32%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -1.49%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Mar 06, 2025 Feb 13, 2025 +7.50%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 29, 2025 +9.32%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 28, 2025 +10.09%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +23.12%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +23.12%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +23.12%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories
Sale (Full) $1,001 - $15,000
Jan 31, 2025 Jan 08, 2025 +19.42%
Congress pfp
Emily Randall D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +21.56%
Congress pfp
Emily Randall D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +16.18%
Congress pfp
Thomas H. Kean, Jr. R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Jan 22, 2025 Dec 16, 2024 +23.68%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories Common Stock
Sale (Partial) $15,001 - $50,000
Dec 31, 2024 Dec 11, 2024 +22.27%
Congress pfp
Virginia Foxx R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +12.46%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $15,001 - $50,000
Dec 16, 2024 Nov 19, 2024 +16.75%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $15,001 - $50,000
Dec 16, 2024 Nov 19, 2024 +16.75%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Dec 16, 2024 Nov 04, 2024 +12.90%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Dec 16, 2024 Nov 04, 2024 +12.90%
Congress pfp
Sheldon Whitehouse D / Senate
AMGN logo
AMGN Amgen Inc
Sale (Partial) $1,001 - $15,000
Oct 10, 2024 Sep 17, 2024 -13.40%
Congress pfp
John James R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2024 Sep 04, 2024 +12.67%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Sep 11, 2024 Aug 19, 2024 +16.75%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $50,001 - $100,000
Aug 20, 2024 Aug 07, 2024 -16.32%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 20, 2024 Aug 02, 2024 -19.22%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 15, 2024 Jul 29, 2024 +21.90%
Congress pfp
Thomas H. Kean, Jr. R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 19, 2024 Jul 23, 2024 +24.55%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 19, 2024 Jul 05, 2024 +24.60%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -9.94%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 +24.54%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 +24.54%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -0.55%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -22.95%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -0.55%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $15,001 - $50,000
Feb 14, 2024 Jan 19, 2024 -22.93%
Congress pfp
Thomas R. Carper D / Senate
ABT logo
ABT Abbott Laboratories
Sale (Partial) $1,001 - $15,000
Feb 02, 2024 Jan 17, 2024 -3.50%
Congress pfp
Michael C. Burgess R / House
AMGN logo
AMGN AMGEN INC.
Sale $15,001 - $50,000
Jan 22, 2024 Jan 02, 2024 -22.18%
Congress pfp
John R. Curtis R / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Dec 15, 2023 Dec 04, 2023 +1.92%
Congress pfp
John James R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Sep 02, 2024 Nov 10, 2023 +12.11%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -28.33%
Congress pfp
Greg Stanton D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 +5.86%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories Common Stock
Purchase $1,001 - $15,000
Nov 01, 2023 Oct 03, 2023 +3.87%
Congress pfp
Greg Stanton D / House
ABT logo
ABT ABBOTT LABORATORIES
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 +5.04%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -24.47%
Congress pfp
Pete Ricketts R / Senate
ABT logo
ABT Abbott Laboratories
Sale (Full) $100,001 - $250,000
Oct 20, 2023 Sep 21, 2023 +3.05%
Congress pfp
John R. Curtis R / House
ABT logo
ABT ABBOTT LABORATORIES
Purchase $1,001 - $15,000
Oct 04, 2023 Sep 13, 2023 +2.14%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories Common Stock
Purchase $15,001 - $50,000
Oct 12, 2023 Sep 13, 2023 +2.14%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 21, 2024 Jul 14, 2023 +0.87%
Congress pfp
Shelley Moore Capito R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $1,001 - $15,000
Jul 17, 2023 Jun 12, 2023 +2.25%
Congress pfp
Josh Gottheimer D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Jun 11, 2023 May 01, 2023 -15.01%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
May 19, 2023 Apr 28, 2023 -15.33%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES
Purchase $1,001 - $15,000
May 19, 2023 Apr 28, 2023 -15.83%